UNC0638, an HMT inhibitor, reduced infarct size in an acute MI model by suppressing fibrosis, inflammation, and apoptosis through the downregulation of SMAD3 and TGF-β signaling [83]. The gene discussed is TGFB1; the disease is myocardial infarction.